Andersen O - Search Results

1

Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis.

Tedeholm H, Piehl F, Lycke J, Link J, Stawiarz L, Burman J, de Flon P, Fink K, Gunnarsson M, Mellergård J, Nilsson P, Sundström P, Svenningsson A, Johansson H, Andersen O. Tedeholm H, et al. Among authors: andersen o. Mult Scler Relat Disord. 2022 Dec;68:104220. doi: 10.1016/j.msard.2022.104220. Epub 2022 Oct 5. Mult Scler Relat Disord. 2022. PMID: 36242804 Free article.

2

No evidence for spumavirus or oncovirus infection in relapsing-remitting multiple sclerosis.

Svenningsson A, Lycke J, Svennerholm B, Gronowitz S, Andersen O. Svenningsson A, et al. Among authors: andersen o. Ann Neurol. 1992 Nov;32(5):711-4. doi: 10.1002/ana.410320518. Ann Neurol. 1992. PMID: 1333176

3

Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.

Lycke J, Andersen O, Svennerholm B, Ben-Menachem E, Horal P, Vahlne A. Lycke J, et al. Among authors: andersen o. Acta Neurol Scand. 1992 Jan;85(1):44-54. doi: 10.1111/j.1600-0404.1992.tb03994.x. Acta Neurol Scand. 1992. PMID: 1546533

4

Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden.

Svenningsson A, Runmarker B, Lycke J, Andersen O. Svenningsson A, et al. Among authors: andersen o. Acta Neurol Scand. 1990 Sep;82(3):161-8. doi: 10.1111/j.1600-0404.1990.tb04483.x. Acta Neurol Scand. 1990. PMID: 2270743

5

Acyclovir concentrations in serum and cerebrospinal fluid at steady state.

Lycke J, Andersen O, Svennerholm B, Appelgren L, Dahlöf C. Lycke J, et al. Among authors: andersen o. J Antimicrob Chemother. 1989 Dec;24(6):947-54. doi: 10.1093/jac/24.6.947. J Antimicrob Chemother. 1989. PMID: 2621178 Clinical Trial.

6

Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope.

Fredman P, Lycke J, Andersen O, Vrethem M, Ernerudh J, Svennerholm L. Fredman P, et al. Among authors: andersen o. J Neurol. 1993 Jun;240(6):381-7. doi: 10.1007/BF00839972. J Neurol. 1993. PMID: 7687665

7

Human spumaretrovirus antibody reactivity in multiple sclerosis.

Lycke J, Svennerholm B, Svenningsson A, Muranyi W, Flügel RM, Andersen O. Lycke J, et al. Among authors: andersen o. J Neurol. 1994 Feb;241(4):204-9. doi: 10.1007/BF00863769. J Neurol. 1994. PMID: 8195818

8

Possible association of HTLV-I infection and dementia.

Lycke J, Svennerholm B, Svenningsson A, Horal P, Nordqvist-Brandt E, Andersen O. Lycke J, et al. Among authors: andersen o. Acta Neurol Scand. 1993 Sep;88(3):199-203. doi: 10.1111/j.1600-0404.1993.tb04216.x. Acta Neurol Scand. 1993. PMID: 8256556

9

Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls.

Svenningsson A, Hansson GK, Andersen O, Andersson R, Patarroyo M, Stemme S. Svenningsson A, et al. Among authors: andersen o. Ann Neurol. 1993 Aug;34(2):155-61. doi: 10.1002/ana.410340210. Ann Neurol. 1993. PMID: 8338339

10

Regional cerebral blood flow in multiple sclerosis measured by single photon emission tomography with technetium-99m hexamethylpropyleneamine oxime.

Lycke J, Wikkelsö C, Bergh AC, Jacobsson L, Andersen O. Lycke J, et al. Among authors: andersen o. Eur Neurol. 1993;33(2):163-7. doi: 10.1159/000116926. Eur Neurol. 1993. PMID: 8467826

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,558 results

Search Page

Filters